Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

 
 
DownloadE-Mail
  Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections

Steller, S., Angenendt, P., Cahill, D. J., Heuberger, S., Lehrach, H., & Kreutzberger, J. (2005). Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections. PROTEOMICS, 5(8), 2048-2055. doi:10.1002/pmic.200401097.

Item is

Dateien

einblenden: Dateien
ausblenden: Dateien
:
Steller et al. - Proteomics.pdf (beliebiger Volltext), 477KB
Name:
Steller et al. - Proteomics.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Öffentlich
MIME-Typ / Prüfsumme:
application/pdf / [MD5]
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
eDoc_access: PUBLIC
Lizenz:
-

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Steller, Sigrid1, Autor
Angenendt, Philipp2, Autor           
Cahill, Dolores J., Autor
Heuberger, Sigrid, Autor
Lehrach, Hans2, Autor           
Kreutzberger, Jürgen2, Autor           
Affiliations:
1Max Planck Society, ou_persistent13              
2Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433550              

Inhalt

einblenden:
ausblenden:
Schlagwörter: Opacity proteins; Pathogen; Phase variation; Protein chip; Vaccine
 Zusammenfassung: Neisseria meningitidis is the most common cause of meningitis and causes epidemic outbreaks. One trait of N. meningitidis, which is associated with most of the currently recognized virulence determinants, is the presence of phase-variable genes that are suspected to enhance its ability to cause an invasive disease. To detect the immune responses to phase-variable expressed proteins, we applied protein microarray technology for the screening of meningitis patient sera. We amplified all 102 known phase-variable genes from N. meningitidis serogroup B strain MC58 by polymerase chain reaction and subcloned them for expression in Escherichia coli. With this approach, we were able to express and purify 67 recombinant proteins representing 66% of the annotated genes. These were spotted robotically onto coated glass slides to generate protein microarrays, which were screened using 20 sera of patients suffering from meningitis, as well as healthy controls. From these screening experiments, 47 proteins emerged as immunogenic, exhibiting a variable degree of seroreactivity with some of the patient sera. Nine proteins elicited an immune response in more than three patients, with one of them, the phase-variable opacity protein OpaV (NMB0442), showing responses in 11 patient sera. This is the first time that protein microarray technology has been applied for the investigation of genetic phase variation in pathogens. The identification of disease-specific proteins is a significant target in biomedical research, as such proteins may have medical, diagnostic, and commercial potential as disease markers.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2005-04-25
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: eDoc: 275619
DOI: 10.1002/pmic.200401097
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: PROTEOMICS
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 5 (8) Artikelnummer: - Start- / Endseite: 2048 - 2055 Identifikator: ISSN: 1615-9853